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ABSTRACT We previously isolated a porcine epidemic diarrhea virus (PEDV) strain,
PC177, by blind serial passaging of the intestinal contents of a diarrheic piglet in
Vero cell culture. Compared with the highly virulent U.S. PEDV strain PC21A, the tis-
sue culture-adapted PC177 (TC-PC177) contains a 197-amino-acid (aa) deletion in the
N-terminal domain of the spike (S) protein. We orally inoculated neonatal, conven-
tional suckling piglets with TC-PC177 or PC21A to compare their pathogenicities.
Within 7 days postinoculation, TC-PC177 caused mild diarrhea and lower fecal viral
RNA shedding, with no mortality, whereas PC21A caused severe clinical signs and
55% mortality. To investigate whether infection with TC-PC177 can induce cross-
protection against challenge with a highly virulent PEDV strain, all the surviving pig-
lets were challenged with PC21A at 3 weeks postinoculation. Compared with 100%
protection in piglets initially inoculated with PC21A, 88% and 100% TC-PC177- and
mock-inoculated piglets had diarrhea following challenge, respectively, indicating incom-
plete cross-protection. To investigate whether this 197-aa deletion was the determinant
for the attenuation of TC-PC177, we generated a mutant (icPC22A-S1Δ197) bearing the
197-aa deletion from an infectious cDNA clone of the highly virulent PEDV PC22A
strain (infectious clone PC22A, icPC22A). In neonatal gnotobiotic pigs, the icPC22A-
S1Δ197 virus caused mild to moderate diarrhea, lower titers of viral shedding, and
no mortality, whereas the icPC22A virus caused severe diarrhea and 100% mortality.
Our data indicate that deletion of this 197-aa fragment in the spike protein can at-
tenuate a highly virulent PEDV, but the virus may lose important epitopes for induc-
ing robust protective immunity.
IMPORTANCE The emerging, highly virulent PEDV strains have caused substantial
economic losses worldwide. However, the virulence determinants are not estab-
lished. In this study, we found that a 197-aa deletion in the N-terminal region of the
S protein did not alter virus (TC-PC177) tissue tropism but reduced the virulence of
the highly virulent PEDV strain PC22A in neonatal piglets. We also demonstrated
that the primary infection with TC-PC177 failed to induce complete cross-protection
against challenge by the highly virulent PEDV PC21A, suggesting that the 197-aa re-
gion may contain important epitopes for inducing protective immunity. Our results
provide an insight into the role of this large deletion in virus propagation and
pathogenicity. In addition, the reverse genetics platform of the PC22A strain was fur-
ther optimized for the rescue of recombinant PEDV viruses in vitro. This break-
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through allows us to investigate other virulence determinants of PEDV strains and
will provide knowledge leading to better control PEDV infections.
KEYWORDS porcine epidemic diarrhea virus, coronavirus, spike protein,
pathogenesis, pathogenicity, virulence, reverse genetics, 3D structural modeling,
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Porcine epidemic diarrhea virus (PEDV) is a highly virulent and contagious porcineenteric pathogen. It causes up to 100% mortality in neonatal piglets under 1 week
of age and milder enteritis in older pigs (1, 2). Since 2010, the emerging, highly virulent
PEDV strains have decimated swine farms in China and spread to other Asian countries,
North and South America, and Europe, causing substantial economic losses (3, 4).
During the first year of PEDV outbreaks in the United States, about 7 million piglets
died, resulting in a $9 million to $1.8 billion annual loss for the U.S. economy (4, 5).
These large-scale PEDV outbreaks ended in 2014. Subsequently, PEDV outbreaks oc-
curred sporadically in the United States (Swine Health Monitoring Surveillance, USDA
[https://www.aphis.usda.gov/]). However, PEDV outbreaks still cause major economic
problems in many Asian countries. For example, it has been estimated that more than
490,000 pigs died due to the outbreak of PEDV during October 2013 to August 2015 in
Japan (6). PEDV belongs to the genus Alphacoronavirus within the family Coronaviridae.
Its 28-kb positive-sense, single-stranded RNA genome contains six open reading frames
(ORFs), encoding polyproteins pp1a and pp1ab that are processed to generate 16
nonstructural proteins (nsp1 to nsp16) and the spike (S), ORF3, envelope (E), membrane
(M), and nucleocapsid (N) proteins.
The glycosylated S protein is a receptor binding ligand that can be divided into S1
and S2 subunits based on functional domains (7). The S1 subunit contains the receptor
binding domains that bind to the putative receptors aminopeptidase N (APN) and sialic
acid (N-acetylneuraminic acid [Neu5Ac], whereas a fusion peptide within the S2 subunit
mediates virus-cell membrane fusion during virus entry (8). Although the cellular
receptor for PEDV is still under study and controversial (9–11), it is hypothesized that a
known neutralizing epitope, the CO-26K equivalent epitope (COE; residues 499 to 638),
within the C-terminal domain (CTD) of S1 contains the APN-binding domain (12). The
N-terminal domain (NTD; residues 19 to 233) of S1 is responsible for sialic acid binding
(8, 13, 14). Also, this NTD is dispensable for PEDV replication in cell culture and pigs
since PEDV variants bearing large deletions (ranging from 194 to 216 amino acids [aa])
within the S1 NTD have been reported (6), including the tissue culture-adapted PC177
(TC-PC177) strain (197-aa deletion; residues 34 to 230) (15) and strain TTR-2 (194-aa
deletion; residues 23 to 216) (16). The 197-aa deletion of the PC177 strain occurred
during the isolation of this virus in Vero cell culture, whereas the TTR-2 strain was
detected in a pig farm in Japan. These viruses are designated the S1 NTD deletion
(NTD-del) type. Similar large deletions in the S1 NTD (about 200 to 230 aa) were found
in porcine respiratory coronavirus ([CoV] PRCV), a naturally occurring mutant of the
enteric alphacoronavirus transmissible gastroenteritis virus (TGEV) (17). PRCV is an
attenuated variant with reduced enteric tropism and increased tropism for the respi-
ratory tract that causes subclinical to mild respiratory disease (18). Additionally, due to
its close antigenic relatedness, infection of PRCV provides partial protective immunity
against TGEV infection (19–21).
To date, the pathogenicity of the S1 NTD-del type of PEDV variants has not been
well established in vivo. Experimental infection of 6-day-old colostrum-deprived piglets
infected with the TTR-2 strain revealed that the virulence of this mutant was reduced
compared with that of the highly virulent strain OKN-1 (22). However, in addition to the
194-aa deletion in the S1 NTD, TTR-2 also contains an additional 28-amino-acid sub-
stitution compared with the sequence of the virulent control OKN-1 strain. These 28
amino acids are located in the ORF1a/b (21 aa), S (6 aa), and N (1 aa) genes and might
also influence the reduced pathogenicity of TTR-2. Whether the large deletion in the
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NTD of S1 alone is responsible for the reduced virulence of PEDV was not confirmed
using standard reverse genetics approaches.
Previously, we constructed a full-length cDNA clone of the highly virulent PEDV
strain PC22A (icPEDV, infectious clone PEDV) (23). To increase the stability of plasmids
and improve recovery of recombinant viruses, we generated an optimized reverse
genetics platform for PEDV, icPC22A. Using this second generation of the reverse
genetics platform, we deleted the 197-aa region in the NTD of S1 from a highly virulent
PEDV strain to confirm the relationship between the S1 NTD and the pathogenicity of
a PEDV strain.
We hypothesized that the 197-aa deletion in S1 NTD can attenuate a PEDV strain in
neonatal piglets but still induce protective immunity against highly virulent PEDV
strains. To test the hypothesis, we inoculated conventional suckling piglets with the
tissue culture-adapted PEDV PC177 (TC-PC177) strain and challenged the surviving pigs
at 3 weeks of age with the highly virulent PEDV PC21A strain. Furthermore, we
generated a deletion mutant virus by introducing the same 197-aa deletion into the S1
subunit of icPC22A (icPC22A-S1Δ197). We then demonstrated that the pathogenicity of
this mutant was reduced in neonatal gnotobiotic (Gn) piglets.
RESULTS
The virulence of TC-PC177 was reduced in conventional suckling piglets. To
evaluate the pathogenicity of TC-PC177, 4-day-old conventional suckling piglets were
orally inoculated with TC-PC177 P10C8, highly virulent PC21A, or phosphate-buffered
saline ([PBS] mock). Clinical signs observed in the acute-infection phase (1 to 11 days
postinoculation [dpi]) are summarized in Table 1. In contrast to the PC21A-inoculated
group, in which all piglets (11/11) developed diarrhea within 1 dpi, 80% (8/10) of
TC-PC177-inoculated piglets had diarrhea with a significantly delayed onset at 2.50 
0.53 dpi. No pigs had diarrhea, and no virus shedding was detected in the mock
inoculation group. No mortality was observed in the TC-PC177 and mock groups,
whereas 55% (6/11) of piglets in the PC21A group died. Evaluation of the fecal
consistency (FC) scores (Fig. 1A; Table 1) displayed lower mean scores in the TC-PC177
group than those in the PC21A group in the first 11 dpi. The highest fecal PEDV RNA
titer appeared later (5 dpi) than that in the PC21A group, and the titer was significantly
lower (P  0.05) in the TC-PC177 group (Fig. 1B and Table 1). The duration of diarrhea
in the TC-PC177-inoculated group was 2.22 2.17 days, which was significantly shorter
than that (7.33  1.18 days) of the PC21A-inoculated group (P  0.05).
Mild and severe villous atrophy were observed in the small intestines of the
TC-PC177- and PC21A-infected piglets, respectively. The villous height-to-crypt depth
(VH/CD) ratios of the duodenum, jejunum, and ileum differed significantly among
groups: the highest ratio was in the mock infection group, midrange ratios were in the
TC-PC177 infection group, and the lowest ratio was in the PC21A infection group
TABLE 1 General litter information and clinical signs of conventional piglets and sows after PEDV inoculation
Inoculum
groupa
Piglet datab Sow data
No. of
pigs
Diarrhea rate
(%)c
Mortality
rate (%)
Onset of
diarrhea
(dpi)
Mean
cumulative FC
score of each
pigd
Duration of
diarrhea
(days)
Onset of
fecal RNA
shedding
(dpi)
Mean highest
fecal RNA
shedding titer
(log10 GE/ml
[dpi]e)
Duration of
diarrhea
(days)
Highest fecal
PEDV RNA
shedding
titer (log10
GE/ml)e
TC-PC177 10 80 (8/10) A 0 (0/10) B 2.50 0.53 A 7.88 5.51 B 2.22 2.17 B 2.00 0.00 10.19 0.50 (5) B ND 6.80
PC21A 11 100 (11/11) A 55 (6/11) A 1.00 0.00 B 17.00 2.00 A 7.33 1.18 A 1 11.81 0.27 (1) A 6.00 9.67
Mock 7 0 (0/7) B 0 (0/7) B ND 0.00 0.00 C 0.00 0.00 C ND ND ND ND
aPiglets in the TC-PC177 group were inoculated with 5 log10 PFU/pig of TC-PC177 P10C8; piglets in the PC21A group were inoculated with 10 log10 genome
equivalents (GE)/pig of wild-type PC21A; piglets in the mock group were inoculated with PBS.
bDifferent uppercase letters indicate a mean significant difference between groups (P  0.05). Values in parentheses are the number of positive animals/number of
animals tested. Data were determined at 1 to 11 dpi. ND, not detected.
cFecal consistency (FC) was scored as follows: 0, solid, 1, pasty, 2, semiliquid; and 3, liquid. An FC score of 2 was considered diarrhea.
dMean value  (sum of FC scores for each piglet)/N, where N is the number of surviving piglets in the period. Scores were calculated for piglets at 1 to 5, 7, 9, and 11
days postinoculation (dpi).
eThe detection limit of PEDV real-time RT-PCR corresponds to 4.8 log10 GE/ml.
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(Fig. 1D). Using immunohistochemistry (IHC) staining, we confirmed that the PEDV N
antigens were sporadically distributed in the intestine of the TC-PC177 piglets, unlike
the extensive antigen signals in the intestine of the PC21A piglets (see Fig. 7A and B).
Notably, among all PEDV-infected piglets, no PEDV antigen-positive cells were detected
FIG 1 Evaluation of the virulence of the PEDV TC-PC177 (P10C8) strain in neonatal, conventional suckling pigs. PC21A- and mock-inoculated
groups were the virulent and negative controls, respectively. (A) Fecal consistency scores postinoculation. Each dot indicates the score of an
individual piglet at different dates; each line represents the mean value of scores in each group. (B) Fecal PEDV RNA shedding profile. Data are
displayed as mean values  standard deviations of each group. Values lower than the detection limit (4.8 log10 GE/ml), such as the mock
inoculation data, were considered negative samples and were not displayed in this figure. (C) Fecal shedding profile of two PEDV-exposed sows.
(D) VH/CD ratios of the small intestine of two (mock) or three piglets (TC-PC177 and PC21A), that died or were euthanized at 3 dpi. Fifteen villi
and crypts were measured in the sections of small intestine among different piglets.
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in any other organs (lungs, spleen, kidneys, liver, and heart) other than the intestines
and lymphocytes.
The two sows were infected with PC21A or TC-PC177 by being exposed to their
virus-shedding piglets. Interestingly, in contrast to 6 days of diarrhea in the PC21A-
exposed sow, the sow infected with TC-PC177 did not show any clinical signs (Table 1).
The overall fecal PEDV RNA shedding titers of the TC-PC177-infected sow were lower
than those of the PC21A-infected sow (Fig. 1C). However, after the PC21A challenge, the
sow in the PC21A group did not develop diarrhea and had low fecal RNA shedding
titers (Table 2), while sows in both the TC-PC177 and mock infection groups had
diarrhea.
TC-PC177 induced incomplete cross-protection against challenge with the
highly virulent PEDV PC21A strain. All surviving piglets were challenged with 12
log10 genome equivalents (GE)/piglet of PC21A (Table 2) at 3 weeks postinoculation. All
pigs (100%) in the mock group, 88% of pigs in the TC-PC177 group, and no pigs in the
PC21A group had diarrhea postchallenge. However, the mock-inoculated group exhib-
ited a significantly longer duration of diarrhea (3.80  0.84 days) than the TC-PC177-
inoculated group (1.88  1.13 days) (P  0.05). No mortality was observed in the three
litters, similar to previous observations that PEDV infection does not cause mortality in
older pigs (2, 24).
Before challenge, pigs in both the TC-PC177- and PC21A-inoculated groups shed
PEDV RNA at low titers constantly (ranging from 7 to 8 log10 GE/ml). From 0 to 1 days
postchallenge (dpc), the shedding titers in the TC-PC177 group increased from 7.36 
1.41 to 8.81  1.64 log10 GE/ml, in contrast to the decreased shedding titers (8.46 
0.09 to 6.55  0.51 log10 GE/ml) in the PC21A group (Fig. 2B). The mock-inoculated
piglets had increased shedding titers from no shedding at 0 dpc to the peak titer of
10.23  0.66 log10 GE/ml within 2 dpc. However, the PEDV RNA shedding titers were
undetectable in the TC-PC177-inoculated group at 7 dpc, they were low in the
PC21A-inoculated group (5.89  0.17 log10 GE/ml), and they were moderate in the
mock-inoculated group (8.24  0.67 log10 GE/ml). To identify which PEDV strains
were shed from the pigs in the TC-PC177 group after challenge, we amplified the
S gene fragment covering the 197-aa deletion region from rectal swab (RS) samples
using a conventional reverse transcription-PCR (RT-PCR) assay developed in our
laboratory (25). We amplified PC21A but not PC177 PEDV from the fecal samples of pigs
in the TC-PC177 group after challenge with the PC21A strain, indicating the dominant
shedding of PC21A virus after challenge (data not shown).
The PEDV virus neutralization (VN) antibody titers in sera collected from piglets at 1
day before challenge (1 dpc) and at 7 dpc are shown in Fig. 2C and D. Similar to
results from our previous report, each serum sample had similar titers against the
homologous and heterologous strains (26). The mean PEDV VN antibody titers in
TC-PC177- and PC21A-inoculated groups were similar at 1 dpc (Fig. 2C). After PC21A
TABLE 2 Clinical signs of pigs postchallenge with the highly virulent strain PC21A
Inoculum
group
Piglet dataa Sow data
No. of
surviving
pigsb
Challenge
age (days
[dpi])
Diarrhea
rate (%)c,d
Mortality
rate (%)d
Onset of
diarrhea
(dpc)
Mean
cumulative
FC score of
each pige
Highest fecal
PEDV RNA
shedding titer
(log10 GE/ml)f
Duration of
diarrhea
(days)
Duration of
diarrhea
(days)
Highest fecal
PEDV RNA
shedding
titer (log10
GE/ml)f
TC-PC177 8 23 (19) 88 (7/8) A 0 (0/8) 1.43 0.53 6.00 2.69 A 8.81 1.65 A 1.88 1.13 B 2 8.00
PC21A 4 24 (20) 0 (0/4) B 0 (0/4) ND 0.00 0.00 B 6.83 0.37 B ND ND 6.61
Mock 5 24 (20) 100 (5/5) A 0 (0/5) 1.80 0.45 6.80 1.03 A 10.23 0.66 A 3.80 0.84 A 1 10.95
aDifferent uppercase letters indicate a mean significant difference between groups (P  0.05). ND, not detected.
bTwo PC177-infected piglets, two mock-infected piglets, and one surviving PC21A-infected piglet were euthanized at the acute phase for histopathological
examination.
cFecal consistency (FC) was scored as follows: 0, solid, 1, pasty, 2, semiliquid; and 3, liquid. An FC score of 2 was considered diarrhea.
dValues in parentheses are the number of positive results/number of animals tested.
eMean value  (sum of FC scores for each piglet)/N, where N is the number of surviving piglets in the period. Scores were calculated for piglets at 1, 2 4, and 6 days
postchallenge (dpc).
fThe detection limit of PEDV real-time RT-PCR corresponds to 4.8 log10 GE/ml.
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challenge, the titers rose significantly (P  0.05) by 7 dpc in the TC-PC177 and mock
inoculation groups but not in the PC21A group (Fig. 2D).
Genomic sequence analysis of TC-PC177 P10C8 revealed additional mutations
compared with TC-PC177. We found an additional 5-nucleotide (nt) deletion in the
ORF3 gene of TC-PC177 P10C8 compared with that of TC-PC177 P2 (GenBank accession
number KM392229) (15). This deletion resulted in an 85-aa C-terminal truncation in the
ORF3 protein (Fig. 3). We also found that this clone has 9 amino acids different from the
genome of PC21A, located in the ORF1a (7 aa) and S (2 aa) genes. Therefore, to
determine whether the 197-aa deletion in S1 NTD alone can attenuate a PEDV strain,
FIG 2 Evaluation of the clinical signs and serum virus neutralization (VN) antibody titers of conventional suckling piglets after challenge with
the highly virulent PEDV PC21A strain. (A) Fecal consistency scores of piglet postchallenge. Dots and lines represent individual values and mean
values, respectively, in each group. (B) Fecal PEDV RNA shedding profile of piglets. Data are shown as mean values  standard deviations of
each group. VN antibody titers of sera collected at 1 day before challenge (C) and at 7 days postchallenge (D) were titrated by CCIF assay. The
titers are expressed as the reciprocal of the highest dilution at which the number of PEDV FFU is blocked 80%.
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FIG 3 (A) Alignment of amino acids of ORF3 proteins of TC-PC177 P10C8 and other PEDV strains. (B) Alignments of amino acids in the N-terminal sequences
(residues 1 to 300) of spike proteins of PEDV strains TC-PC177 P2, TC-PC177 P10C8, wild-type PC21A, and PC22A P4. (C) Schematic amino acid differences
between TC-PC177 P10C8 and PC21A. A deletion is indicated by a dash (-).
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we generated a recombinant virus, icPC22A-S1Δ197, by deleting the 197-aa region
from the S gene of the highly virulent icPC22A virus and performed a pathogenesis
study in Gn pigs (see below).
The optimized full-length infectious cDNA clone of PC22A was more stable and
more efficient in rescue of recombinant viruses. The original six-fragment infectious
clone described by Beall et al. (23) was compromised by the low stability of subclones
B and E and low virus yields after transfection associated with poor virus replication in
cell culture, complicating our ability to isolate attenuated mutants. We determined the
boundaries of these new subclone junctions by trial and error to avoid the toxicity
effects of PEDV sequences in Escherichia coli. Consequently, the second-generation
infectious clone, designated icPC22A, was now captured within five plasmids that
replicated more stably in E. coli (data not shown), allowing for more efficient recovery
of recombinant viruses. Compared with the genomic sequence of the parental PC22A
virus of the previous six-fragment version, our icPC22A contains a GGC insertion
(nucleotide positions 22029 to 22031) in the S1 C-terminal domain, resulting in the
replacement of an aspartic acid by a glycine and a histidine (D466GH). This insertion
first appeared in one batch of the passage 4 (P4) TC-PC22A virus. It replicated more
efficiently than previous passages of TC-PC22A. Moreover, this insertion was genetically
stable through the 160th passage (27). Therefore, we retained this insertion in plasmid
E to increase the efficacy of rescue of the recombinant viruses from Vero cell cultures.
Recombinant viruses were rescued and characterized in Vero cell culture. After
electroporation of the mixture of full-length genomic and N gene transcripts into Vero
cells, we observed the formation of syncytia, which are the typical cytopathic effects
(CPE) of PEDV infection, for both recombinant viruses (icPC22A and icPC22A-S1Δ197) at
2 to 3 days posttransfection (Fig. 4A). The 197-aa deletion is the only difference
between the viral genomes of icPC22A-S1Δ197 and the virulent control icPC22A. There
were no other differences between the genomes of icPC22A-S1Δ197 and icPC22A. CPE
developed more slowly with icPC22A-S1Δ197 virus than with the icPC22A virus. We
harvested both supernatants at 4 to 5 days posttransfection and passaged them in Vero
cells one more time to generate the P1 virus. Titers of these P1 viruses were 7.63 log10
PFU/ml (icPC22A) and 5.51 log10 PFU/ml (icPC22A-S1Δ197). Sanger sequencing data
revealed that the appropriate genetic marker, the C-to-G substitution at nucleotide site
16507, existed in the genomes of both icPC22A and icPC22A-S1Δ197 but not in the
genome of the parental PC22A P4 virus (Fig. 4B). The 197-aa deletion was confirmed for
icPC22A-S1Δ197 virus by RT-PCR, followed by sequence analysis.
The replication of recombinant viruses in Vero cells was assessed by multistep
growth kinetics at a multiplicity of infection (MOI) of 0.01 (Fig. 4C). The replication of
icPC22A virus was comparable to that of PC22A P4; however, titers of icPC22A-S1Δ197
virus were about 3 to 4 log10 lower than those of the other two viruses at 36 h
postinoculation. The morphology of the plaques of icPC22A was comparable to that of
the parental virus (Fig. 4D).
To confirm the loss of the sialic acid binding domain in icPC22A-S1Δ197 virus, we
performed neuraminidase (NA) treatment of Vero cells, followed by virus inoculation.
Cell surface sialic acids were removed by neuraminidase digestion before virus inocu-
lation, as described previously (14). After PEDV inoculation, Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 2.5% fetal bovine serum (FBS) was used as the
maintenance medium to inhibit proteinase activity to block virus spreading. Compared
with the corresponding mock-infected control cells without NA treatment before PEDV
inoculation, the numbers of fluorescent focus units (FFU) of both icPC22A and icPC22A-
S1Δ197 viruses were decreased in the NA-treated Vero cells (Fig. 5). However, we
observed a 92.7% reduction in icPC22A virus, which was significantly higher than the
25.8% reduction in the icPC22A-S1Δ197 virus (P  0.05).
These results indicate that the recombinant viruses from our optimized infectious
clones were effectively rescued in Vero cell cultures. The icPC22A virus propagated
similarly to its parental virus, PC22A P4, yet the icPC22A-S1Δ197 virus replicated less
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FIG 4 Characterization of recombinant viruses. (A) Cytopathic effects (CPE) of recombinant viruses occurred at 2 days posttransfection of the
mixture of full-length genomic RNA and N gene transcripts into Vero cells. (B) Sanger sequencing chromatogram of a silent mutation
(nucleotide position 16507; C to G) was identified exclusively in the recombinant viruses icPC22A (P1) and icPC22A-S1Δ197 (P1). (C) Multistep
growth kinetics of two recombinant viruses and parental PC22A (P4). Vero cells were inoculated with each virus at an MOI of 0.01.
Supernatants were sampled at different time points and titrated for TCID50 values in 96-well plates, and virus titers were calculated using the
Reed-Muench method (58). (D) Plaque assay of two recombinant viruses, parental PC22A (P4), TC-PC177 P10C8, and mock inoculation. Images
were taken at 3 days postinoculation.
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efficiently than the other two. We also confirmed the loss of most sialic acid binding
activity of icPC22A-S1Δ197 virus in Vero cell culture.
Compared with the virulence of icPC22A virus, the virulence of icPC22A-
S1197 was reduced in neonatal Gn piglets. To determine whether the recombinant
icPC22A virus is also highly virulent and whether the 197-aa deletion attenuated the
icPC22A-S1Δ197 virus in vivo, 5-day-old Gn piglets were divided into three groups and
orally inoculated with icPC22A (n  3; 100 PFU/pig) or icPC22A-S1Δ197 (n  4; 100
PFU/pig) virus or mock inoculated (n  2; PBS).
The clinical signs of the Gn piglets in the acute phase of infection are summarized
in Table 3. All icPC22A-infected piglets developed diarrhea within 1 dpi (Table 1 and
Fig. 6A), with a peak shedding titer of 11.48  0.17 log10 GE/ml at 1 dpi (Fig. 6B). These
piglets developed severe clinical signs, became moribund, and were euthanized at 2
dpi. At necropsy, we observed thin and transparent intestinal walls of different sections
of the intestines, which are characteristic for neonatal piglets infected with the highly
virulent PEDV (Fig. 6D). Histopathological examination revealed severe villous atrophy
in the small intestine. The VH/CD ratios of icPC22A-inoculated piglets (jejunum, 1.23 
0.23) were significantly lower than those of the age-matched mock-inoculated piglets
(jejunum, 10.11  1.52) (P  0.05). IHC staining showed icPEDV N proteins extensively
in the small intestine (Fig. 7). Comparing these data with results for PC21A-infected
conventional piglets euthanized at the acute phase, as well as PC22A-inoculated Gn
piglets in our previous study (23), indicates that the icPC22A virus is highly pathogenic
in newborn Gn piglets, similar to wild-type PC21A and the PC22A challenge pool (28).
FIG 5 Neuraminidase treatment infectivity assay. (A) Indirect immunofluorescent assay of Vero cells
pretreated with neuraminidase (NA) or PBS (NA) and inoculated with recombinant virus icPC22A or
icPC22A-S1Δ197. After inoculation, cells were maintained in DMEM containing 2.5% FBS. At 16 h
postinoculation, cells were fixed, and the PEDV antigens were stained using mouse anti-PEDV N antibody
as the primary antibody. (B) Percentage of fluorescent focus units (FFU) of sialic acid-dependent infection
assay. Neuraminidase- or PBS-treated Vero cell monolayers were inoculated with equal amounts of virus
(350 FFU/well).
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On the other hand, all the icPC22A-S1Δ197-infected piglets showed less severe
diarrhea than the icPC22A-infected piglets (Table 3 and Fig. 6B) and significantly
delayed onset of fecal virus RNA shedding (3.25  0.50 dpi) compared with the
icPC22A-infected piglets (1.00  0.00 dpi) (P  0.05). The highest viral RNA shedding
titer within 10 dpi was 8.88  0.17 log10 GE/ml in the icPC22A-S1Δ197 group, a value
which was significantly lower than the peak titer (11.48  0.17 log10 GE/ml) of the
icPC22A group (P  0.05). The intestinal VH/CD ratio of the icPC22A-S1Δ197 group was
significantly higher than that of icPC22A group (Fig. 6C), corresponding to less trans-
parency of the small intestine of the icPC22A-S1Δ197-infected piglet than of the
icPC22A-infected piglets (Fig. 6D). We detected scattered PEDV N protein antigens in
the small intestine (Fig. 7) and colon in this piglet. Similar to the result for TC-PC177, no
alteration of tissue tropism was observed in the icPC22A-S1Δ197-infected piglets. These
findings suggest that icPC22A-S1Δ197 was less virulent than icPC22A. Collectively,
these data support the hypothesis that the 197-aa deletion is responsible for the
attenuation of icPC22A-S1Δ197.
3-D structural analyses of the S proteins of icPC22A and icPC22A-S1197. To
investigate the structural differences of the S proteins between the two recombinant
viruses icPC22A and icPC22A-S1Δ197, we constructed three-dimensional (3-D) models
of the S protein trimers by the homology modeling technique. As shown in Fig. 8A, the
S1 subunit of icPC22A can be divided into domain 0, domain A, domain B, domain C,
and domain D. Domain 0 (residues 34 to 230) is lacking in the S1 subunit of icPC22A-
S1Δ197 (Fig. 8B), indicating that the 197-aa deletion corresponds to domain 0. In the S
protein trimer of icPC22A, domain 0 is located at the greatest distance from the trimeric
axis that does not contribute to the trimer formation (Fig. 8C). Therefore, the deletion
of domain 0 in the S protein trimer of icPC22A-S1Δ197 would not interfere with the
trimer formation.
Domain B of the S1 subunit, which includes the known neutralizing epitope COE
(residue 499 to 638), is located at the most distal end from the viral membrane. Domain
A is located between domain 0 and domain B in the S protein trimer of icPC22A. Thus,
the deletion of domain 0 in the S protein trimer of icPC22A-S1Δ197 would not interfere
with the neutralizing epitope COE. However, domain 0 in the S protein trimer of
icPC22A is located near the nonneutralizing epitopes SS2 (residues 748 to 755) and SS6
(residues 764 to 771), which are the subsequent residues after domain D that are closest
to the S2 subunit.
DISCUSSION
In this study, we demonstrated that the pathogenicity of the S1 NTD-del type of
PEDV mutants, TC-PC177 and icPC22A-S1Δ197, in neonatal piglets was attenuated, as
characterized by no mortality, extended incubation time, milder intestinal lesions, and
lower fecal PEDV RNA shedding titers than with the highly virulent PEDV strain.
Importantly, no changes in tissue tropism were observed for these viruses. For TC-
TABLE 3 General group information and clinical signs of Gn piglets after inoculation with recombinant virusesa
Inoculum
groupb
No. of
piglets
Diarrhea rate
(%)c,d
Mortality
rate (%)d
Onset of
diarrhea
(dpi)
Highest FC
score of
each piglet
Duration of
diarrhea
(days)
Onset of
fecal RNA
shedding
(dpi)f
icPC22A-S1Δ197 4 100 (4/4) A 0 (0/4) B 3.25 0.50 A 2.50 0.58 7.67 0.58 3.25 0.50
icPC22A 3 100 (3/3) A 100 (3/3) A 1.00 0.00 B 3.00 0.00 NA (3)e 1
Mock 2 0 (0/2) B 0 (0/2) B ND 1.00 ND ND
aDifferent uppercase letters indicate a mean significant difference between groups (P  0.05). ND, not detected.
bPiglets in the icPC22A-S1Δ197 group were inoculated with 100 PFU/pig of virus; piglets in the icPC22A group were inoculated with 100 PFU/pig of virus; piglets in
the mock inoculation group were inoculated with PBS.
cFecal consistency (FC) was scored as follows: 0, solid, 1, pasty, 2, semiliquid; and 3, liquid. An FC score of 2 was considered diarrhea.
dValues in parentheses are the number of positive results/number of animals tested.
eNA, not available. Since all icPC22A-inoculated piglets became moribund and were euthanized by 2dpi, this value could not be determined.
fThe detection limit of PEDV real-time RT-PCR corresponds to 4.8 log10 GE/ml.
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PC177 P10C8, the 85-aa-truncated ORF3 and other 9-aa alterations in ORF1a and S may
also contribute to the attenuated phenotype, as a similar C-terminally truncated ORF3
protein also exists in some attenuated PEDV strains, such as CV777 (GenBank accession
number KT323979) and DBI865 (GenBank accession number HQ537432). Therefore, the
application of reverse genetics was essential for the final confirmation of the role of the
197-aa deletion in PEDV attenuation.
FIG 6 Evaluation of the virulence of recombinant viruses icPC22A and icPC22A-S1Δ197 in 5-day-old Gn piglets.
Numbers of piglets in each group were as follows: icPC22A, n  3; icPC22A-S1Δ197, n  4; mock, n  2. (A) Fecal
consistency scores of individual Gn piglets. Each line represents the mean value in each group. Three icPC22A
piglets became moribund and were euthanized at 2 dpi; one icPC22A-S1Δ197-infected diarrheic piglet and one
mock-inoculated piglet were euthanized at 3 dpi for histopathological examination. (B) Fecal PEDV RNA shedding
profile of each group. Data are shown as mean values  standard deviations of groups. (C) VH/CD ratios of Gn
piglets euthanized at 2 to 3 dpi. (D) Necropsy images show that transparent intestine was observed in the Gn piglet
inoculated with icPC22A but not in icPC22A-S1Δ197-infected or mock-inoculated piglets.
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The milder clinical signs, virus shedding profiles, and histopathological lesions of TC-
PC177-inoculated piglets were similar to those of TTR-2-infected neonatal, colostrum-
deprived piglets (22). Suzuki et al. did not detect PEDV antigens in the duodenum of the
four TTR-2-inoculated pigs. In our study, although PEDV antigens were not detected in
the duodenum of the icPC22A-S1Δ197-infected piglet that was euthanized during the
acute infection phase, we detected sporadic PEDV-positive enterocytes in the duodenum of
TC-PC177-infected cesarean-derived, colostrum-deprived (29), and conventional suckling
FIG 7 Immunohistochemistry staining of PEDV N proteins in the jejunum sections of piglets that died or were euthanized at 2 to 3 dpi
(magnification, 200): PC21A (A), TC-PC177 (B), icPC22A (C), icPC22A-S1Δ197 (D), mock inoculation (E). The brown signals represent the
PEDV antigens in enterocytes. Acidic polysaccharides, including sialylated mucin, were stained with 1% alcian blue and appear as cyan
signals, mainly indicating goblet cells in the intestine. Severe villous atrophy can be observed in different sections of intestine of PC21A-
and icPC22A-exposed piglets.
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piglets. Also, we found that the PEDV antigen distributions in different sections of
intestines in icPC22A-S1Δ197- and icPC22A-infected piglets were similar (Fig. 7). The
discrepant PEDV antigen distributions in different sections of the intestines (from
duodenum to colon) may be due to the use of different strains in the two studies, the
limited number of animals being evaluated, and the different timing of euthanasia.
Overall, icPC22A-S1Δ197 replicated less efficiently than icPC22A in vitro (Fig. 4C and D).
This suggests that the NTD of S1 is not essential for PEDV replication in vivo and in vitro;
however, this domain increases virus replication levels in vitro and enhances virulence
in vivo.
As one of the most variable regions in the PEDV genome, the S1 NTD correlated with
different sialic acid binding activities and pathogenicities of PEDV strains in pigs. The S
indel (insertion and deletion) type of PEDV strains were characterized by an amino acid
insertion (residues 161 to 162) and two deletions (residues 59 to 62 and 140) in the S1
NTD although they shared a similar genomic backbone with the highly virulent strains
(30). It has been demonstrated that the virulence of S indel strains is reduced compared
with that of the highly virulent strains (31, 32). Interestingly, a recent study revealed
that a highly virulent non-S indel strain, GDU, had sialic acid binding activity while an
S indel strain, UU, did not (14). This finding was similar to our neuraminidase treatment-
dependent infectivity results with icPC22A and icPC22A-S1Δ197 (Fig. 5). For the enteric
FIG 8 Three-dimensional structural analyses of the S proteins of icPC22A and icPC22A-S1Δ197. The S1
subunit monomers of icPC22A (A) and icPC22A-S1Δ197 (B) and S protein trimers of icPC22A (C) and
icPC22A-S1Δ197 (D) were modeled based on the cryo-EM structure of human coronavirus NL63 S protein
from the Protein Data Bank (PDB accession number 5SZS) (60). The 197-amino-acid region, designated
domain 0, is highlighted in orange, whereas other domains in the S1 subunit are highlighted in blue; the
S2 subunit is in gray.
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coronavirus TGEV, virions of the wild-type strain but not an attenuated mutant, m10, of
the Purdue-115 strain, bound to mucin-like glycoprotein purified from porcine enteric
epithelial cells in vitro (33). The m10 variant contained point mutations in the sialic acid
binding domain in S1 NTD and was attenuated in pigs. Therefore, the binding to sialic
acid-rich glycoproteins, such as mucus in the intestine, may be important for stabilizing
enteric coronaviruses, including the highly virulent PEDV strain, and may facilitate initial
virus attachment to cellular receptors in vivo. However, it is difficult to monitor and
quantify the initial infection step between the highly virulent and S1 NTD-del strain in
vivo. In a previous report, inoculation of a highly virulent U.S. PEDV strain led to the
infection of 100% of epithelial cells in the jejunum of a piglet as early as 12 h
postinoculation although virus shedding and villous atrophy were not observed at this
early time point (1). However, with the delayed virus replication (Fig. 1 and 6), only
limited PEDV antigens could be detected in the enterocytes of S1 NTD-del variant
TC-PC177- or icPC22A-S1Δ197-infected piglets via IHC (Fig. 7). In IHC of alcian blue-
stained tissue, the antigen signals of TC-PC177 or icPC22A-S1Δ197 (Fig. 7) were not
necessarily colocalized with the sialylated mucin-rich region, especially goblet cells. The
mechanism of sialic acid binding involved in initial PEDV infection in vivo is clearly an
important step in pathogenesis and requires more detailed future studies.
Mutants of various species of coronaviruses containing a large deletion in their spike
glycoproteins have been identified, including TGEV (34), feline infectious peritonitis
virus (FIPV) (35, 36), mouse hepatitis coronavirus (MHV) (37), and bat coronavirus HKU2
(38). In many cases, such mutants display attenuation and/or changes in tissue tropism
in the host. For PEDV, similar to the observation in the previous TTR-2 study (22), the
loss of S1 NTD also did not change the enteric tropism of TC-PC177 and icPC22A-
S1Δ197 in piglets. This phenomenon differs from what occurred with another porcine
enteric alphacoronavirus, TGEV: the loss of the S1 NTD of TGEV changed the enteric
virus into a respiratory variant virus, PRCV (20). One explanation is that PEDV replicates
exclusively in the intestine while TGEV replicates in both the intestine and respiratory
tract (21, 39). Such diverse tissue tropisms may be due to different receptor usage
and/or proteolytic processing of the S proteins between PEDV and TGEV. For many
years, the TGEV receptor, porcine aminopeptidase N (pAPN), was also considered to be
the putative receptor of PEDV (40–43). However, recent studies revealed that PEDV
could infect pAPN knockout cell lines (11), but the protease activity of pAPN enhanced
PEDV infection (10), suggesting that pAPN is not the cellular receptor for PEDV.
Moreover, it is well known that extracellular proteases, such as trypsin, enhance the
entry and egress of PEDV in cell culture (44, 45), suggesting that PEDV propagation may
depend on the protease-rich environment in the intestine. For TGEV, a furin-like
protease cleavage motif (KRKYR) is located upstream of the fusion peptide of the S
protein (46). Along with recognizing different cellular receptors, TGEV can also bind to
two types of sialic acids (47), Neu5Ac and N-glycolylneuraminic acid (Neu5Gc); however,
the PEDV S1 NTD attaches only to Neu5Ac (8). Such a difference in carbohydrate
binding may also restrict the enteric tropism of S1 NTD-del PEDV variants.
Based on the lower growth kinetics in vitro and reduced pathogenicity of icPC22A-
S1Δ197 in piglets, we conclude that the S1 NTD-del type of PEDVs replicate less
effectively than the highly virulent strains. Such defective replication of TC-PC177 might
induce less robust immune responses than PC21A in conventional suckling piglets. Our
results demonstrated that the primary infection with TC-PC177 did not provide signif-
icant cross-protection against challenge with the highly virulent strain PC21A in vivo.
After each piglet was challenged with a high dose (12 log10 GE) of PC21A virus, none
of the piglets in the PC21A group showed clinical signs, but 88% of the TC-PC177-
inoculated and 100% of the mock-inoculated piglets developed diarrhea (Table 2)
although similar levels of VN antibody titers were detected in the TC-PC177-inoculated
and the PC21A-inoculated piglets at 1 day prechallenge in vitro (Fig. 2C). At 7 dpc, the
VN antibody titers of piglets in the TC-PC177 group were significantly higher than those
in the PC21A group. After challenge, the higher level of PC21A replication in the
PC177-inoculated piglets than in the PC21A-inoculated piglets could have been re-
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sponsible for the induction of the higher VN antibody levels in the TC-PC177 group
than in the PC21A group (Fig. 2B and C). It is likely that the existing homologous
immunity, induced by PC21A infection, protected more efficiently against PC21A
infection after challenge than the heterologous immunity induced by the primary
TC-PC177 infection. The robust immune responses likely protected the PC21A-
inoculated piglets from homologous challenge. In the three-dimensional structural
analysis (Fig. 8), we discovered that domain 0, containing the deleted 197-aa region in
the S protein of TC-PC177, potentially does not interfere with trimer formation and the
neutralizing epitopes COE (residue 499 to 638) and 2C10 (residues 1368 to 1374) (29).
However, the deletion of domain 0 may influence two nonneutralizing B cell epitopes,
SS2 and SS6 (48), which may contribute to the conformational change of the S2 subunit
during the virus-cell membrane fusion process. Recently, a publication reported that
domain 0 of PEDV contains neutralizing epitopes (49). However, we detected that
TC-PC177 infection in pigs induced similar VN antibody titers against both homologous
and PC21A viruses (Fig. 2C and D), suggesting that the deletion of domain 0 did not
significantly affect the induction of serum neutralizing antibodies in pigs and/or that
these VN epitopes within domain 0 do not play a predominant role in the induction of
serum VN antibodies. Based on the partial cross-protection in the TC-PC177 group
piglets, we assume that the deletion of the 197-aa domain may affect the induction of
protective mucosal and cellular immune responses, which will be studied in the future.
To date, only a few PEDV reverse genetics platforms have been reported. Li et al. (50)
developed a platform for a cell culture-adapted PEDV vaccine strain, DR13, using
targeted RNA recombination technology. Jengarn and colleagues constructed a bac-
terial artificial chromosome (BAC) bearing the genomic cDNA of PEDV strain AVCT12
and recovered the recombinant viruses from a Vero cell line transfected with pAPN (51).
However, the infectious cDNA clone contained a 52-nt deletion at the 3= end of the S
gene, resulting in a 7-aa early termination of the S protein and the loss of the start
codon of the ORF3 gene. These mutations probably facilitated the rescue of recombi-
nant viruses in Vero cells but may impair the pathogenicity of recombinant AVCT12
(rAVCT12) in vivo. A review article summarizing different reverse genetics platforms for
PEDV was recently published (52).
Our second-generation PEDV infectious clone was designed to circumvent problems
noted in our previous icPEDV (23), such as low recovery yields of recombinant viruses
and a need to increase the stability of subclones B and E. This second-version infectious
clone should facilitate increased adaptation in Vero cells as well as maintain the
virulence of the recombinant virus in vivo. We noted that a conserved GGC insertion
(nucleotide site 22029; D to GH), located upstream of the putative receptor binding
domain in the S1 CTD, occurred in the genome of a batch of P4 PC22A virus,
corresponding to increased virus titers in Vero cell cultures, but not in the earlier
passages or the template of the six-fragment icPEDV generated by Beall et al. (23). After
electroporation, the initial infection with the recombinant viruses that contained the
GGC insertion caused CPE within 2 to 4 days posttransfection, implying that the rescue
of recombination viruses in Vero cells was significantly enhanced compared with that
of the previous icPEDV. Particularly, icPC22A was still highly virulent in neonatal piglets,
suggesting that the insertion of GGC did not impair the pathogenicity of this recom-
binant virus in vivo. The biological function of this insertion will be investigated in the
future. More recently, an infectious cDNA clone of the highly virulent Chinese strain
AH2012/12 was reported (53) using a similar strategy as that used with icPC22A.
However, the CPE of rAH2012/12 occurred only after the supernatants of transfected
Vero cells were passaged three times, implying less efficiency in rescuing recombinant
viruses than that of the optimized icPC22A platform described in this study.
In this study, we confirmed that the virulence of TC-PC177, an S1 NTD-del type of
PEDV, was reduced in neonatal piglets without changes in tissue tropism but with
induction of cross-neutralizing antibody. Primary infection with TC-PC177 in conven-
tional suckling piglets failed to induce cross-protection against the challenge with the
highly virulent strain PC21A at 3 weeks postinfection. Furthermore, we optimized the
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infectious clone of the highly virulent PEDV strain PC22A and verified that the recom-
binant virus icPC22A is highly pathogenic in neonatal piglets. Using this reverse
genetics platform, we confirmed that the NTD of the S1 subunit of S protein is a
virulence determinant of a highly virulent PEDV.
MATERIALS AND METHODS
Cell lines and viruses. Vero cells (ATCC number CCL81) were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) (Gibco, Carlsbad, CA) supplemented with 5% FBS, 100 U/ml penicillin, 100 g/ml
streptomycin, and 250 ng/ml amphotericin B. After PEDV inoculation, the Vero cells were maintained in
DMEM supplemented with 0.3% tryptose phosphate broth, 100 U/ml penicillin, 100 g/ml streptomycin,
and 10 g/ml trypsin (Gibco, Carlsbad, CA, USA) (15, 54). The isolated TC-PC177 was passaged in Vero
cells 10 times. A plaque-purified clone 8, designated TC-PC177 P10C8, was used as the inoculum for
conventional suckling piglets. Two highly virulent PEDV strains of U.S. origin, PC21A and PC22A, were
detected and isolated from the same PED outbreak and have only three single nucleotide polymor-
phisms (15, 55). PC21A was used in the conventional pig study as the virulent control, whereas PC22A
was used to generate the infectious cDNA clone.
Construction of the full-length cDNA clone of PC22A. The strategy employed to construct the
infectious cDNA clone of PC22A was described previously (23). To increase the stability of plasmids
replicating in E. coli and the number of recombinant viruses recovered in cell culture, we divided the
genomic cDNA of PC22A at the fourth passage into five fragments. The viral RNA was extracted using an
RNeasy minikit (Qiagen, Germany) and reverse transcribed into cDNA using SuperScript III reverse
transcriptase (Invitrogen, Carlsbad, CA). The five truncated genomic cDNAs, fragments A to E, were
amplified by PCR with PrimeSTAR GXL polymerase (TaKaRa, Japan) and were cloned into high-copy-
number plasmid pUC19 (NEB, Ipswich, MA) (Fig. 9). Junctions between A/B, B/C, and C/D were joined by
a unique nonpalindromic SapI site located at nucleotide positions 5752, 9654, and 14047. Fragments D
and E were divided by a BsaI site located at nucleotide position 20418. Two naturally occurring BsaI sites,
located within fragment D (nucleotide position 16507) and fragment E (nucleotide position 24335), were
removed by introducing synonymous mutations. Fragment A contained a T7 promoter located upstream
of the first nucleotide, whereas fragment E harbored a 23-nt poly(A) tail at the 3= end. We constructed
a mutant E plasmid by directly deleting the 591 nt encoding the 197 aa from the S1 region using
NEBuilder HiFi DNA assembly master mix (NEB, Ipswich, MA). Together with fragments A to D, this mutant
E fragment was used for the generation of recombinant virus icPC22A-S1Δ197.
Recovery of recombinant viruses. The full-length cDNA was assembled as previously described (56,
57). Briefly, five cDNA fragments (A to E) were digested individually with respective restriction enzymes
and gel purified using a QIAquick gel extraction kit (Qiagen, Germany). The five fragments in equal molar
ratios were ligated using T4 ligase (NEB, Ipswich, MA) at 4°C overnight. The ligated cDNA was used as the
FIG 9 Schematic organization of a PEDV genome and the constructions of the full-length infectious cDNA clone.
(A) Organization of a PEDV genome, including the ORF1a/b, spike (S), ORF3, envelope (E), membrane (M), and
nucleocapsid (N) genes. (B) Five fragments comprising a full-length cDNA clone of PC22A. Two asterisks indicate
BsaI sites in the PEDV genome that were removed by introducing silent mutations (nucleotide position 16507, C
to G; nucleotide position 24332, A to G). In comparison with the genomic sequence of icPEDV (23), a GGC insertion
is located at nucleotide position 22029, as indicated. (C) Mutant fragment E containing the 197-aa deletion in the
S1 NTD. UTR, untranslated region; (A)23, 23-nt poly(A) tail.
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template for in vitro transcription using a mMessage mMachine T7 transcription kit (Ambion, Austin, CA,
USA). To increase the efficiency of recovery of recombinant virus as previously described (23), the PEDV
nucleocapsid cDNA containing a T7 promoter and poly(A) tail was amplified from plasmid E using
primers PEDV-N-F (5=-ATATGGATCCATCGTAATACGACTCACTATAGATGGCTTCTGTCAGTTTTCAGG-3=) and
PEDV-N-R (5=-TTTTTTTTAATTTCCTGTGTCGAAGATCTCGTTGATAATTTCAACGG-3=), and then the purified
cDNA was transcribed, followed by poly(A) tailing using a HiScribe T7 ARCA mRNA kit (NEB, Ipswich, MA,
USA). The mixture of N gene transcripts and the full-length genomic RNA were electroporated into 8 
106 Vero cells with four pulses at 450 V and 50 F using a Gene Pulser II electroporator (Bio-Rad, Hercules,
CA, USA). After recovery in growth medium for about 24 h, the cells were washed with PBS twice and
cultured in the maintenance medium supplemented with 10 g/ml trypsin for 4 to 6 days.
Identification of the marker mutation. The supernatant of electroporated Vero cells was harvested
at 4 to 6 days postinoculation (dpi) and passaged one more time in Vero cells to generate the
first-passage (P1) virus stock. Viral RNA was extracted from the supernatant of P1 virus using an RNeasy
minikit and reverse transcribed into cDNA using SuperScript III reverse transcriptase as described above.
To identify the presence of the silent mutation of a natural BasI site in fragment D (nucleotide position
16507; nsp13), a fragment was amplified by PCR using primers PEDV-15792-F (5=-CAAGGAGGAGAGCG
TTAAGTCATCCTATG-3=) and PEDV-16634-R (5=-TGCGTTGAGTGACAACGTTGTAGTCCT-3=). The fragment
was gel-purified and sequenced using primer PEDV-16322-F (5=-GCGGTCGACTCACTTTGTGTGAAAGC-3=).
Growth kinetics. Vero cell monolayers in six-well plates were infected with each virus at a multi-
plicity of infection (MOI) of 0.01. After a 1-h absorption, the cell monolayers were washed twice with PBS
and then maintained in the maintenance medium as described above. The supernatants were collected
at multiple time points, and the virus titers were determined in 96-well plates as the number of 50%
tissue culture infective doses (TCID50) by the Reed-Muench method (58).
Study design of experimental infection in pigs. Three PEDV-naive sows were assigned to three
groups (TC-PC177, PC21A, and mock inoculation), and each was housed in individual biosafety level 2
rooms for natural farrowing. At 4 days of age, the piglets were inoculated orally with TC-PC177 P10C8
(n 10) at a dose of 5 log10 PFU/piglet. Wild-type PC21A infection (n 11; 10 log10 GE/piglet) and mock
infection (n 9, PBS) were used as the positive and negative controls, respectively (31). We used 10 log10
GE/piglet for PC21A inoculation because 7.7 log10 GE of this strain caused a 10-day-old piglet severe
diarrhea within 1 dpi (55). One pig from the mock group, two diarrheic pigs from the TC-PC177 group,
and two diarrheic pigs from the PC21A group were randomly selected and euthanized at 3 dpi for
histopathological examinations. All other piglets were kept for the evaluation of morbidity, mortality, and
fecal PEDV RNA shedding unless piglets became moribund and were euthanized. At 19 dpi (TC-PC177
group) and 20 dpi (mock and PC21A groups), the piglets were challenged orally with the PC21A strain
with 12 log10 GE/pig. This challenge dose for 3-week-old PEDV-exposed pigs was optimized in our
previously study (31). We observed clinical signs for 7 days postchallenge (dpc). Blood samples of piglets
were collected at 1 day prior to the challenge and at 7 dpc for serological assays.
Gnotobiotic (Gn) pigs were used to evaluate the pathogenesis of two infectious clone-derived
recombinant viruses, icPC22A and icPC22A-S1Δ197. The Gn pigs were derived and raised as described
previously (59). Nine Gn piglets were assigned to three experimental groups, and piglets in each group
were housed in the same isolator. At 5 days of age, piglets were orally inoculated with the plaque-
purified, first passage of icPC22A (n  3; 100 PFU/pig) or icPC22A-S1Δ197 (n  4; 100 PFU/pig) or mock
inoculated (n  2; PBS). This dose corresponded to 1,000 median pig diarrhea doses (PDD50) of PC22A
in 4-day-old cesarean-derived, colostrum-deprived piglets, as we determined previously (28). At the acute
phase of infection, one diarrheic piglet of each PEDV-inoculated group was euthanized for histopatho-
logical examination.
After inoculation, all piglets in these experimental groups were evaluated daily for clinical signs, such
as diarrhea, vomiting, anorexia, and depression. Fecal consistency was examined by collection of rectal
swabs, and the fecal consistency was scored as follows: 0, solid; 1, pasty; 2, semiliquid (mild diarrhea); and
3, liquid (severe diarrhea). Total fecal RNA was extracted using a MagMax RNA isolation kit (Austin, CA,
USA), and the PEDV N gene was detected by TaqMan real-time reverse-transcription quantitative PCR
(RT-qPCR) as described previously (55). All animal experiments were performed according to the
protocols approved by Institutional Animal Care and Use Committee (IACUC) of the Ohio State University
(OSU).
Genomic sequencing of PEDV strains. The original inoculum of TC-PC177 P10C8 was sent to the
University of Minnesota Genomic Center (St. Paul, MN) for next-generation sequencing as described
previously (60). We determined the genome sequence of PC22A P4, the template for icPC22A in this
study, by Sanger sequencing (Plant-Microbe Genomics Facility, OSU).
Histopathological examination and IHC staining. At necropsy, duodenum, three sections of the
jejunum (proximal, middle, and distal), ileum, colon, and other major organs (heart, liver, lungs, kidneys,
spleen, and mesenteric lymph nodes) were collected and fixed in 10% formalin. All tissues were trimmed,
processed, embedded in paraffin, and sectioned with routine procedures (55). The immunohistochemical
(IHC) staining procedure was performed as described previously, using a nonbiotin polymerized horse-
radish peroxidase system (BioGenex Laboratories, San Ramon, CA, USA) and monoclonal antibody
SD6-29 (gift of Eric Nelson and Steven Lawson, South Dakota State University) targeting PEDV nucleo-
capsid (N) proteins as the primary antibody. Tissues were counterstained with hematoxylin. To stain the
sialylated mucus, the intestine tissues were treated with 1% alcian blue at room temperature for 5 min.
Ratios of villous height to crypt depth (VH/CD) of the duodenum, middle jejunum, and ileum of
individual piglets in the acute infection phase were measured using a computerized imaging system
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(MetaMorph, Olympus, Japan) as described previously (55). For each intestinal section, 15 villi and crypts
were measured.
VN assay. The virus neutralizing (VN) antibody titers against PEDV were evaluated by fluorescent
focus reduction VN assay as described previously (31). Briefly, 50 l of 4-fold-diluted serum was
incubated with an equal volume of PC22A or TC-PC177 containing 200 fluorescent focus units (FFU) at
37°C for 1 h. Vero cells were inoculated with the serum-virus mixtures at 37°C for 4 h. After a washing
step, the cell monolayers were cultured in DMEM containing 5% FBS to inhibit trypsin activity. At 16 h
postinoculation, a PEDV-specific cell culture immunofluorescence (CCIF) assay was conducted by staining
the cells with the PEDV N monoclonal antibody SD6-29 followed by fluorescein isothiocyanate (FITC)-
labeled goat anti-mouse antibody (Invitrogen, Carlsbad, CA). The VN titer of a serum sample was
expressed as the reciprocal of the highest dilution of a sample causing an 80% reduction in the number
of FFU.
Neuraminidase treatment infectivity assay. Monolayers of Vero cells in six-well plates were
pretreated with 200 l of 250 mM neuraminidase (NA) from Clostridium welchii (Sigma, St. Luis, MO) or
of PBS at 37°C for 2 h. After treatment, the cells were washed twice, followed by inoculation with 350 FFU
of recombinant virus icPC22A or icPC22A-S1Δ197 with trypsin (10 g/ml) at 37°C for 1 h. Next, the
inocula were removed from the cells, DMEM containing 2.5% FBS was added, and cells were incubated
at 37°C for 16 h. The number of PEDV-infected Vero cell foci was determined by CCIF assay as described
above (26).
Three-dimensional structural analysis of the S proteins of icPC22A and icPC22A-S1197. The
Protein Data Bank cryo-electron microscopy (cryo-EM) structure of the S protein trimer of human
coronavirus NL63 at a resolution of 3.4 Å was used (PDB accession number 5SZS) (60). The sequence
identities between the S proteins of the two recombinant PEDVs, icPC22A and icPC22A-S1Δ197, and the
human coronavirus NL63 S protein were 43.5% and 47.5%, respectively. Sequence alignments were
generated using MOE-Align in the Molecular Operating Environment (MOE), version 2015.10 (Chemical
Computing Group, Inc., Quebec, Canada). Three-dimensional (3-D) models of the S protein trimers of
PEDV icPC22A and icPC22A-S1Δ197 were constructed by the homology modeling technique using
MOE-Homology in MOE as previously described (61–63). For each homology modeling in MOE, we
obtained 10 intermediate models and selected the intermediate 3-D models with the best scores
according to the generalized Born/volume integral methodology (64). The 3-D structures were thermo-
dynamically optimized by energy minimization using the MOE and an Amber 10:EHT force field (65, 66)
combined with the generalized Born model of aqueous solvation implemented in MOE.
Statistical analysis. The statistical analyses were performed using GraphPad Prism, version 6.0.
Comparisons of VH/CD ratios, diarrhea rates, mortality rates, mean cumulative FC scores, duration of
diarrhea, peak fecal PEDV RNA shedding titers before challenge between different PEDV strains, and
percentage of FFU were analyzed by one-way analysis of variance (ANOVA). Values of onset of diarrhea
and peak fecal PEDV RNA shedding titers postchallenge were analyzed by Student’s t test. A P value of
less than 0.05 was considered significantly different.
Accession number(s). Newly determined sequences were deposited in the GenBank under the
following accession numbers: PC22A P4 for icPEDV (23), KX683006; TC-PC177 P10C8 KY499261; and
PC22A P4 for icPC22A (this study), KY499262.
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